Skip to Content

Label Changes for:

Capoten (Captopril Tablets, USP)

December 2014

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

December 2014


Drug Interactions

*The following was added:

  • Dual blockade…RAS… Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy. In general, avoid combined use of RAS inhibitors … other agents that block the RAS


August 2012


  • Do not co-administer Aliskiren with Capoten in patients with diabetes…